News

Collagen Hybridizing Peptides (CHPs) Elucidate Ursolic Acid's Efficacy in Collagen Homeostasis

Tissue fibrosis, pathologically characterized by the excessive and dysfunctional deposition of extracellular matrix (ECM) components, notably collagen, remains a significant challenge in chronic disease management. Fibrosis accounts for nearly half of all mortality in the United States. Effective therapeutic strategies must engage a dual mechanism, simultaneously arresting neo-collagenesis and actively degrading existing, pathological collagen...
View Details

CHPs Contribute to Abdominal Aortic Anurrysm (AAA) Research)

Abdominal Aortic Aneurysm (AAA) is a life-threatening condition characterized by the extensive remodeling and breakdown of the extracellular matrix (ECM). Understanding the factors governing aortic instability - particularly the micro/nanoscale changes - is paramount for improving AAA management. A new publication, "Nano-mechanical Mapping of Human and Porcine Abdominal Aortic Aneurysm" uses advanced imaging techniques...
View Details

CHP Staining: Unlocking a New Therapeutic Strategy for Fibrosis

Fibrosis, the pathological accumulation of collagen and other ECM components, is a major health concern implicated in an estimated ⅓ of all natural deaths. While current anti-fibrotic drugs aim to slow progression, advanced fibrosis is often left untreated, leaving transplantation the only remaining option in many cases. A new therapeutic approach is focusing on...
View Details

Damaged collagen detected by collagen hybridizing peptide as efficient diagnosis marker for early hepatic fibrosis

Liver fibrosis, a significant pathological consequence of chronic liver disease and damage, is characterized by the excessive accumulation of extracellular matrix (ECM) proteins. This build up of non-functional scar tissue progressively replaces healthy tissue in the liver, leading to conditions such as cirrhosis, liver failure, and heightened risk of liver cancer. With a high...
View Details

Resolving fibrosis by stimulating HSC-dependent extracellular matrix degradation

Fibrosis is not just characterized by extracellular matrix (ECM) component deposition, but it’s better described as an imbalance between the production and breakdown of the ECM. Current treatments for fibrosis largely focus on stopping ECM production, but there is a significant, untapped potential in promoting its breakdown. Matrix metalloproteinases (MMPs) are enzymes that degrade...
View Details